Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DRX - Compass

K-Number: K223842 · 2023-01-20

Decision Date2023-01-20
Product CodeKPR
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

DRX - Compass is a medical device manufactured by Carestream Health, Inc.. It received FDA 510(k) clearance on 2023-01-20 under approval number K223842. The device is classified under product code KPR. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DRX - Compass?

DRX - Compass is a medical device that received FDA 510(k) clearance on 2023-01-20. It is manufactured by Carestream Health, Inc.. The 510(k) number is K223842.

When was DRX - Compass approved by the FDA?

DRX - Compass received FDA 510(k) clearance on 2023-01-20, under approval number K223842.

What company makes DRX - Compass?

DRX - Compass is manufactured by Carestream Health, Inc..

What is the FDA product code for DRX - Compass?

The FDA product code for DRX - Compass is KPR.

Other Devices by Carestream Health, Inc.

View all 23 devices →

Related Devices (Code: KPR)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.